ID22481A - Preparasi bahan farmasi baru mengandung air untuk pembuatan aerosol bebas propelan - Google Patents

Preparasi bahan farmasi baru mengandung air untuk pembuatan aerosol bebas propelan

Info

Publication number
ID22481A
ID22481A IDW990549A ID990549A ID22481A ID 22481 A ID22481 A ID 22481A ID W990549 A IDW990549 A ID W990549A ID 990549 A ID990549 A ID 990549A ID 22481 A ID22481 A ID 22481A
Authority
ID
Indonesia
Prior art keywords
propelants
preparation
making
contain water
new pharmaceutical
Prior art date
Application number
IDW990549A
Other languages
English (en)
Indonesian (id)
Inventor
Bernhard Freund
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7815979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22481(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID22481A publication Critical patent/ID22481A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
IDW990549A 1996-12-20 1997-12-16 Preparasi bahan farmasi baru mengandung air untuk pembuatan aerosol bebas propelan ID22481A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19653969A DE19653969A1 (de) 1996-12-20 1996-12-20 Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole

Publications (1)

Publication Number Publication Date
ID22481A true ID22481A (id) 1999-10-21

Family

ID=7815979

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990549A ID22481A (id) 1996-12-20 1997-12-16 Preparasi bahan farmasi baru mengandung air untuk pembuatan aerosol bebas propelan

Country Status (38)

Country Link
US (3) US20010008632A1 (pl)
EP (2) EP1230916A3 (pl)
JP (1) JP4659160B2 (pl)
KR (1) KR100496723B1 (pl)
CN (1) CN1097455C (pl)
AR (1) AR008721A1 (pl)
AT (1) ATE235887T1 (pl)
AU (1) AU740543B2 (pl)
BG (1) BG64433B1 (pl)
BR (1) BRPI9713596C1 (pl)
CA (1) CA2275392C (pl)
CO (1) CO4920211A1 (pl)
DE (2) DE19653969A1 (pl)
DK (1) DK0946146T3 (pl)
EE (1) EE03949B1 (pl)
EG (1) EG23981A (pl)
ES (1) ES2196388T3 (pl)
HR (1) HRP970694B1 (pl)
HU (2) HU228494B1 (pl)
ID (1) ID22481A (pl)
IL (1) IL130464A (pl)
MY (1) MY124547A (pl)
NO (1) NO320652B1 (pl)
NZ (1) NZ336825A (pl)
PE (1) PE32899A1 (pl)
PL (1) PL189511B1 (pl)
PT (1) PT946146E (pl)
RS (1) RS49803B (pl)
RU (1) RU2219906C2 (pl)
SA (1) SA97180756B1 (pl)
SI (1) SI0946146T1 (pl)
SK (1) SK282910B6 (pl)
TR (1) TR199901408T2 (pl)
TW (1) TW438605B (pl)
UA (1) UA64736C2 (pl)
UY (1) UY24813A1 (pl)
WO (1) WO1998027959A2 (pl)
ZA (1) ZA9711370B (pl)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615422A1 (de) 1996-04-19 1997-11-20 Boehringer Ingelheim Kg Zweikammer-Kartusche für treibgasfreie Dosieraerosole
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1326642A2 (en) * 2000-09-29 2003-07-16 Board of Trustees operating Michigan State University Catecholamine pharmaceutical compositions and methods
YU33103A (sh) * 2000-10-31 2006-05-25 Boehringer Ingelheim Pharma Gmbh. & Co.Kg. Formulacija rastvora za inhalaciju sa soli tiotropijuma
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
EA007604B1 (ru) * 2000-10-31 2006-12-29 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Ингаляционная композиция в виде раствора с солью тиотропия
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
NZ550304A (en) * 2001-10-26 2008-05-30 Dey L P An antimicrobial preservative-free albuterol inhalation solution for the relief of bronchospasm in children with asthma
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
DE10216036A1 (de) 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
EP1531795A4 (en) 2002-05-02 2011-02-23 Harvard College FORMULATIONS FOR LIMITING THE RETENTION OF LUNG INFECTIONS
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
PT1530464E (pt) * 2002-08-14 2008-08-28 Boehringer Ingelheim Pharma Formulação de aerossol para a inalação contendo um agente anticolinérgico
EP1531866A1 (en) * 2002-08-29 2005-05-25 Cipla Ltd. Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20050107417A1 (en) * 2003-07-28 2005-05-19 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
US20050042176A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a steroid
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050059643A1 (en) * 2003-08-05 2005-03-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a steroid and a betamimetic
DE102004001451A1 (de) * 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US20050203088A1 (en) * 2004-01-09 2005-09-15 Boehringer Ingelheim International Gmbh Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE602004025988D1 (de) 2004-05-25 2010-04-22 Enel Distribuzione Spa Verfahren und vorrichtung zur erkennung der verdrahtungsphase einer beliebigen unbekannten phasenspannung relativ zu einer referenzphasenspannung
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
WO2006125153A2 (en) * 2005-05-18 2006-11-23 Pulmatrix Inc. Formulations for alteration of biophysical properties of mucosal lining
EP1917253B1 (de) * 2005-08-15 2015-01-07 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
JP2009537474A (ja) * 2006-05-19 2009-10-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング イプラトロピウムブロマイド及びサルブタモールスルフェートを含有するエアロゾル製剤
CA2652699C (en) * 2006-05-19 2014-11-04 Boehringer Ingelheim International Gmbh Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
EP2205310B1 (en) * 2007-09-13 2015-08-26 Medtronic, Inc. Medical electrical lead
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
PT2621488T (pt) 2010-09-29 2019-02-12 Pulmatrix Operating Co Inc Pós secos catiónicos
EP4008326A1 (en) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
CN103501791B (zh) * 2011-05-03 2016-05-18 奇斯药制品公司 用于通过吸入给药的改良皮质类固醇悬浮制剂
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US20150136130A1 (en) 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
KR20150135328A (ko) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 티오트로피움 건조 분말
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EP3297607B1 (en) * 2015-05-18 2020-07-22 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
CN109925300A (zh) * 2017-12-19 2019-06-25 北京盈科瑞创新药物研究有限公司 一种福多司坦雾化吸入用溶液制剂及其制备方法
EP4188327B1 (en) 2020-07-31 2025-05-28 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
EP0505374B1 (en) * 1990-10-16 1997-04-23 Mayor Pharmaceuticals Laboratories,Inc. Vitamin-mineral treatment methods and compositions
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
BR9609307B1 (pt) * 1995-06-27 2010-03-09 preparação farmacêutica para produção de aerossóis inaláveis isentos de propelentes para administração nos pulmões, bem como aerossol compreendendo a mesma.
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536916A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Kg Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
EP0808627A2 (de) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19620509A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19644646A1 (de) * 1996-10-26 1998-04-30 Mann & Hummel Filter Filter, insbesondere zur Filtrierung des Schmieröls einer Brennkraftmaschine
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US20060239930A1 (en) * 1997-08-04 2006-10-26 Herbert Lamche Process for nebulizing aqueous compositions containing highly concentrated insulin
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt

Also Published As

Publication number Publication date
US20090185983A1 (en) 2009-07-23
RU2219906C2 (ru) 2003-12-27
RS49803B (sr) 2008-06-05
PL189511B1 (pl) 2005-08-31
ZA9711370B (en) 1998-06-22
EP1230916A2 (de) 2002-08-14
PL334185A1 (en) 2000-02-14
PE32899A1 (es) 1999-04-23
UA64736C2 (uk) 2004-03-15
EP0946146B1 (de) 2003-04-02
HRP970694A2 (en) 1998-10-31
MY124547A (en) 2006-06-30
EP0946146A2 (de) 1999-10-06
HUP0000520A3 (en) 2000-10-30
EE9900307A (et) 2000-02-15
CN1097455C (zh) 2003-01-01
US20090099225A1 (en) 2009-04-16
HUP0000520A2 (hu) 2000-09-28
BRPI9713596C1 (pt) 2021-05-25
US20010008632A1 (en) 2001-07-19
DE59709722D1 (de) 2003-05-08
BR9713596B8 (pt) 2013-02-19
NZ336825A (en) 2001-09-28
HU0600044D0 (en) 2006-03-28
AU740543B2 (en) 2001-11-08
CO4920211A1 (es) 2000-05-29
BG103482A (bg) 2000-01-31
TR199901408T2 (xx) 1999-08-23
SK282910B6 (sk) 2003-01-09
HU227012B1 (en) 2010-04-28
JP4659160B2 (ja) 2011-03-30
HU228494B1 (en) 2013-03-28
AU5663698A (en) 1998-07-17
DE19653969A1 (de) 1998-06-25
BG64433B1 (en) 2005-02-28
CA2275392A1 (en) 1998-07-02
NO320652B1 (no) 2006-01-09
EG23981A (en) 2008-02-27
SK81499A3 (en) 2000-01-18
WO1998027959A3 (de) 1998-08-13
DK0946146T3 (da) 2003-04-22
TW438605B (en) 2001-06-07
CA2275392C (en) 2004-06-29
EE03949B1 (et) 2003-02-17
IL130464A (en) 2004-12-15
CN1240347A (zh) 2000-01-05
NO993004L (no) 1999-06-18
SI0946146T1 (en) 2003-10-31
YU28499A (sh) 2001-09-28
IL130464A0 (en) 2000-06-01
WO1998027959A2 (de) 1998-07-02
HK1022846A1 (en) 2000-08-25
KR100496723B1 (ko) 2005-06-22
KR20000057683A (ko) 2000-09-25
SA97180756B1 (ar) 2006-04-28
BR9713596B1 (pt) 2013-01-08
EP1230916A3 (de) 2003-02-05
BR9713596A (pt) 2000-04-04
PT946146E (pt) 2003-08-29
ES2196388T3 (es) 2003-12-16
JP2001507343A (ja) 2001-06-05
ATE235887T1 (de) 2003-04-15
NO993004D0 (no) 1999-06-18
UY24813A1 (es) 2000-09-29
HRP970694B1 (en) 2005-06-30
AR008721A1 (es) 2000-02-09

Similar Documents

Publication Publication Date Title
PT946146E (pt) Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante
DE69507787D1 (de) Doppelwandiger Aerosolbehälter
NO20005218D0 (no) Farmasøytisk aerosolpreparat
ATE236617T1 (de) Aerosol-arzneiformulierungen
AR000211A1 (es) Recipiente hermético
SI0920302T2 (sl) Farmacevtski aerosolni sestavek
DE69502111D1 (de) Aerosolabgabevorrichtung
DE69600409D1 (de) Aerosol-Behälter
DE69801022D1 (de) Aerosolbehälter
IT1273514B (it) Procedimento per la preparazione di un gel micro-mesoporoso
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
ID16709A (id) Kontainer penyemprot
IT1285728B1 (it) Impianto per lo scarico di materiali incoerenti da contenitori
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
KR970016154U (ko) 밀폐용기
ID18263A (id) Proses pembuatan polietilena tereftalat
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
ID15957A (id) Pencegahan pemotongan tetesan-tetesan menjadi ukuran-ukuran aerosol
KR960014419U (ko) 폼제형 에어졸 용기
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
FI102809B1 (fi) Lääkesäiliö
FI960116A0 (fi) Menetelmä ruostumattomien nelikulmaputkien valmistamiseksi
KR950014223U (ko) 공기 청향제 용기
KR960008221U (ko) 양변기 내장용 절수통